IP Library Patent Application 15301837
Patent Application
App. No. 15/301,837

GENDER SPECIFIC SYNTHETIC NUTRITIONAL COMPOSITIONS AND NUTRITIONAL SYSTEMS COMPRISING THEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/301,837
Abstract

Gender specific synthetic nutritional compositions for infants of up to 2 months of age wherein, the concentration of alpha-lactalbumin is adapted based on that found in HM produced for an infant of the same gender and age, and nutritional systems comprising them.

Claims (18)

1 . A gender specific synthetic nutritional composition for an infant up to 2 months of age wherein, the concentration of alpha-lactalbumin in the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

2 . A gender specific synthetic nutritional composition according to claim 1 wherein, the concentration of alpha-lactalbumin is adapted to a male or female infant of 1 to 2 months of age and wherein, if the concentration of alpha-lactalbumin is adapted to a male infant it is 1802.2 mg to 4630.3 mg per L and, if the concentration of alpha-lactalbumin is adapted to a female infant it is 2067.9 mg to 4630.3 mg per L.

3 . A gender specific synthetic nutritional composition according to claim 1 wherein the concentration of alpha-lactalbumin is adapted to a male or female infant of up to 1 month of age and wherein, if the concentration of alpha-lactalbumin is adapted to a male infant it is 1771.5 mg to 4701.11 g per Land, if the concentration of alpha-lactalbumin is adapted to a female infant it is 1386 mg to 4511.6 mg per L.

4 . A composition according to claim 1 wherein the gender specific synthetic nutritional composition is selected from the group consisting of: infant formula, and a composition for infants that is intended to be added to or diluted with human milk.

5 . A method of preparing a composition comprising: measuring out an appropriate amount of a gender neutral synthetic nutritional composition and mixing it with an additive and/or diluent to prepare a composition comprising a gender specific synthetic nutritional composition for an infant up to 2 months of age wherein, the concentration of alpha-lactalbumin in the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

6 . A nutritional system comprising a gender specific synthetic nutritional composition selected from the group consisting of a gender specific synthetic nutritional composition adapted to a male or female infant of 1 to 2 months of age and wherein, if the concentration of alpha-lactalbumin is adapted to a male infant it is 1802.2 mg to 4630.3 mg per L and, if the concentration of alpha-lactalbumin is adapted to a female infant it is preferably 2067.9 mg to 4630.3 mg per L; and a gender specific synthetic nutritional composition adapted to a male or female infant of up to 1 month of age and wherein, if the concentration of alpha-lactalbumin is adapted to a male infant it is 1771.5 mg to 4701.11 g per L and, if the concentration of alpha-lactalbumin is adapted to a female infant it is 1386 mg to 4511.6 mg per L.

7 . A nutritional system according to claim 6 comprising at least one gender specific synthetic nutritional composition for a male infant, at least one gender specific nutritional composition for a female infant wherein, the male and female gender specific synthetic nutritional compositions are for infants of the same age.

8 . A nutritional system according to claim 7 wherein, if the gender specific nutritional compositions are for infants up to 1 month of age the alpha-lactalbumin concentration is higher in the male gender specific nutritional composition than in the male gender specific synthetic nutritional composition and, if the gender specific nutritional compositions are for infants 1 to 2 months of age the alpha-lactalbumin concentration is higher in the female gender specific nutritional composition than in the male gender specific synthetic nutritional composition.

9 . A nutritional system according to claim 6 comprising gender specific synthetic nutritional compositions for infants of more than 2 months of age wherein, the concentration of alpha-lactalbumin in said gender specific synthetic nutritional compositions does not differ by gender for infants of the same age.

10 . A nutritional system according to claim 6 comprising gender neutral synthetic nutritional compositions for infants of more than 2 months of age.

11 . (canceled)

12 . A method for use to treat, prevent or mitigate sub optimal growth and development of an infant comprising administering a gender specific synthetic nutritional composition to an infant wherein, the concentration of alpha-lactalbumin in the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

13 . A method for providing an optimum amount of alpha-lactalbumin to an infant comprising:

administering a gender specific synthetic nutritional composition wherein, the concentration of alpha-lactalbumin in the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

14 . (canceled)

15 . A kit for providing an optimized amount of total alpha-lactalbumin to an infant, in particular an infant of up to 2 months of age the kit comprising:

a. a gender neutral synthetic nutritional composition; and

b. a label indicating dosage requirements for an infant so as to arrive at a gender specific nutritional composition for an infant up to 2 months of age wherein, the concentration of alpha-lactalbumin in the composition is adapted based on that found in human milk produced for an infant of the same gender and age.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2017
From: AFFOLTER, MICHAEL; THAKKAR, SAGAR; DE CASTRO, CARLOS ANTONIO
To: NESTEC S.A.
Reel/Frame 043171/0363 →